Serum lipoprotein changes in dogs with renal disease

Area of Science:

• Veterinary Medicine
• Nephrology
• Cardiovascular Science

Background:

• Renal disease in humans is linked to dyslipidemia, accelerating kidney injury and cardiovascular disease.
• Lipoprotein profiles in dogs with renal disease remain under-investigated.
• Canine chronic kidney disease (CKD) and nephrotic syndrome (NS) are associated with specific lipid alterations.

Purpose of the Study:

• To investigate lipoprotein profiles in dogs with CKD and NS.
• To determine the correlation between dyslipidemia severity and CKD progression markers.
• To compare lipoprotein alterations in dogs with CKD versus NS.

Main Methods:

• Prospective study involving 29 dogs with CKD, 5 dogs with NS, and 12 healthy controls.
• Lipoprotein electrophoresis to quantify low-density lipoproteins (LDL), very low-density lipoproteins (VLDL), and high-density lipoproteins (HDL).
• Standard measurement of serum cholesterol, creatinine, urinalysis, and urine protein-to-creatinine ratio.

Main Results:

• Dogs with CKD and NS consistently showed dyslipidemia, characterized by decreased HDL and variable increases in LDL and VLDL.
• Nephrotic syndrome (NS) cases exhibited a proportionally greater increase in VLDL compared to CKD cases.
• Dyslipidemia was present even when serum cholesterol concentrations were within the normal reference range.

Conclusions:

• Canine CKD presents with dyslipidemia analogous to human renal disease.
• Altered lipoprotein metabolism may contribute to the pathogenesis of renal disease in dogs.
• Further research is needed to elucidate the role of lipoproteins in canine kidney disease progression.